Palliativmedizin in der Pneumologie oder Pneumologie in der Palliativmedizin – eine Stellungnahme

Palliativmedizin - chronisch-obstruktive Lungenerkrankung

end-of-life-care - chronic obstructive pulmonary disease

Literatur

• 1 Abernethy A P, Currow D C, Frith P, Fazekas B S, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.  BMJ. 2003;  327 523-528
• 2 Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson I J. Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer.  J Palliat Med. 2010;  13 1109-1118
• 3 Boyd E A, Lo B, Evans L R, Malvar G, Apatira L, Luce J M, White D B. „It’s not just what the doctor tells me: „factors that influence surrogate decision-makers” perceptions of prognosis.  Crit Care Med. 2010;  38 1270-1275
• 4 Boyd K, Murray S A. Recognising and managing key transitions in end of life care.  BMJ. 2010;  341 c4863
• 5 Bundesärztekammer 2004 .Grundsätze zur ärztlichen Sterbebegleitung. 1298-1299
• 6 Bürgerliches Gesetzbuch 2009 .Drittes Gesetz zur Änderung des Betreuungsrechtes. 
• 7 Byock I. Improving palliative care in intensive care units: identifying strategies and interventions that work.  Crit Care Med. 2006;  34 S302-S305
• 8 Campbell M L, TemplinT, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea.  J Palliat Med. 2010;  13 285-290
• 9 Curtis J R. Palliative and end-of-life care for patients with severe COPD.  Eur Respir J. 2008;  32 796-803
• 10 Degner L F, Sloan J A. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer.  J Pain Symptom Manage. 1995;  10 423-431
• 11 Detering K M, Hancock A D, Reade M C, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial.  BMJ. 2010;  340 c1345
• 12 Gore J M, Brophy C J, Greenstone M A. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.  Thorax. 2000;  55 1000-1006
• 13 Habraken J M, Willems D L, de Kort S J, Bindels P J. Health care needs in end-stage COPD: a structured literature review.  Patient Educ Couns. 2007;  68 121-130
• 14 Jennings A L, Davies A N, Higgins J P, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst; 2001 Rev.CD002066
• 15 Lanken P N, Terry P B, Delisser H M. et al . An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.  Am J Respir Crit Care Med. 2008;  177 912-927
• 16 Li J, Girgis A. Supportive care needs: are patients with lung cancer a neglected population?.  Psychooncology. 2006;  15 509-516
• 17 Lynn J, Ely E W, Zhong Z. et al . Living and dying with chronic obstructive pulmonary disease.  J Am Geriatr Soc. 2000;  48 S91-100
• 18 Magnussen H, Heigener D F, Bausewein C. Palliativmedizin in der Pneumologie.  Pneumologie. 2009;  63 289-295
• 19 Mathers C D, Loncar D. Updated projections of global mortality and burden of disease, 2002 – 2030: data sources, methods and results.  World Health Organisation. 2005; 
• 20 Mularski R A, Campbell M L, Asch S M. et al . A review of quality of care evaluation for the palliation of dyspnea.  Am J Respir Crit Care Med. 2010;  181 534-538
• 21 Nava S, Sturani C, Hartl S. et al . End-of-life decision-making in respiratory intermediate care units: a European survey.  Eur Respir J. 2007;  30 156-164
• 22 Nelson J E, Bassett R, Boss R D. et al . Models for structuring a clinical initiative to enhance palliative care in the intensive care unit: a report from the IPAL-ICU Project (Improving Palliative Care in the ICU).  Crit Care Med. 2010;  38 1765-1772
• 23 Nelson J E, Cox C E, Hope A A, Carson S S. Chronic critical illness.  Am J Respir Crit Care Med. 2010;  182 446-454
• 24 Reck M, von Pawel J, Zatloukal P. et al . Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.  J Clin Oncol. 2009;  27 1227-1234
• 25 Simon S T, Higginson I J, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst; 2010 Rev.CD007354
• 26 Temel J S, Greer J A, Muzikansky A. et al . Early palliative care for patients with metastatic non-small-cell lung cancer.  N Engl J Med. 2010;  363 733-742
• 27 White D B, Evans L R, Bautista C A, Luce J M, Lo B. Are physicians’ recommendations to limit life support beneficial or burdensome? Bringing empirical data to the debate.  Am J Respir Crit Care Med. 2009;  180 320-325